The State Service of Ukraine on Medicines and Drugs Control confirmed its legitimacy in the case on LLC “Criogenservice”

Опубліковано 22.07.2020 о 14:28

Taking into account the disinformation appearing in the social media regarding the activitiy of the State Service of Ukraine on Medicines and Drugs Control related to the LLC “Criogenservice” we inform on the following.

04 June 2020 the District Administrative Court in Kiev ruled the desicion on the claim of the citizen of Ukraine to the State Service of Ukraine on Medicines and Drugs Control and LLC “Criogenservice” in the case № 640/16002/19 on recognition of the acts or omissions as unlawful.

The claim was on recognition of the acts of the State Service of Ukraine on Medicines and Drugs Control on issuance to the LLC “Criogenservice” a license to cunduct economic activities on manufacture of medicinal products and a license to conduct wholesale and retail trade of medicinal products as unlawful; to revoke above mentioned licenses. Besides, the claim was to recognize the omissions of the State Service of Ukraine on Medicines and Drugs Control as unlawful exactly – non-performance of unscheduled inspection on abiding to the legislation on licensing by the LLC “Criogenservice”.

The claim to the State Service of Ukraine on Medicines and Drugs Control and LLC “Criogenservice” was rejected entirely by the District Administrative Court in Kiev.

Thus the Court has confirmed tha actions of the State Service of Ukraine on Meicines and Drugs Control to be lawful and in compliance with Ukraine’s legislation.

Link to the court judgment: http://reyestr.court.gov.ua/Review/89920897.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Print button Версія для друку

Попередня

The State Service of Ukraine on Medicines and Drugs Control participated in the online briefing regarding Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health

Наступна

Changes to the Order on conducting confirmation of compliance of the medicinal products manufacture conditions to the GMP requirements came into force